IC
PTHS

Ikarian Capital’s Pelthos Therapeutics PTHS Stock Holding History

Ikarian Capital’s Portfolio PTHS Stock Details PTHS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.25M Hold
256,598
– – 0.78% 35
2026
Q1 		$5.39M Buy
256,598
+840
+0.3% +$19.9K 0.44% 57
2025
Q4 		$7.93M Buy
255,758
+193,307
+310% +$5.58M 0.62% 47
2025
Q3 		$1.75M Buy
+62,451
New +$1.52M 0.18% 105
2025
Q2 		– Sell
-44,085
Closed -$626K – 193
2025
Q1 		$626K Buy
+44,085
New +$755K 0.08% 108

Other funds holding PTHS

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
DP
Diadema Partners Morristown, New Jersey $791M AUM 245.83% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Ikarian Capital's PTHS Position: Q2 2026 in Review

Ikarian Capital held its Pelthos Therapeutics (PTHS) position steady in Q2 2026 at 256,598 shares worth $7.25M. The position accounts for 0.78% of the portfolio, ranked #35.

Ikarian Capital first reported a position in PTHS in Q1 2025 and has held it in 5 quarters since. The position peaked at $7.93M in Q4 2025. 24 funds tracked by Wall St. Rank hold PTHS as of Q2 2026.

  • Ikarian Capital held 256,598 shares of Pelthos Therapeutics worth $7.25M as of Q2 2026.
  • Ikarian Capital left its Pelthos Therapeutics share count unchanged in Q2 2026.
  • Pelthos Therapeutics made up 0.78% of Ikarian Capital's portfolio in Q2 2026, its #35 holding.
  • Ikarian Capital first reported a position in Pelthos Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • Ikarian Capital's Pelthos Therapeutics position peaked at $7.93M in Q4 2025.
  • 24 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q2 2026.

Based on Ikarian Capital's 13F filing for Q2 2026, filed 14 Aug 2026.